“Cardiac muscle”的意思、由来-开放百科全书

Cardiac muscle (also called heart muscle or myocardium) is one of three types of vertebrate muscles, with the other two being skeletal and smooth muscles. It is an involuntary, striated muscle that constitutes the main tissue of the walls of the heart. The myocardium forms a thick middle layer between the outer layer of the heart wall (the epicardium) and the inner layer (the endocardium), with blood supplied via the coronary circulation. It is composed of individual heart muscle cells (cardiomyocytes) joined together by intercalated discs, encased by collagen fibres and other substances that form the extracellular matrix.

Cardiac muscle contracts in a similar manner to skeletal muscle, although with some important differences. An electrical stimulation in the form of an action potential triggers the release of calcium from the cell's internal calcium store, the sarcoplasmic reticulum. The rise in calcium causes the cell's myofilaments to slide past each other in a process called excitation contraction coupling.

Diseases of heart muscle are of major importance. These include conditions caused by a restricted blood supply to the muscle including angina pectoris and myocardial infarction, and other heart muscle disease known as cardiomyopathies.

Structure

Gross anatomy

Cardiac muscle tissue or myocardium forms the bulk of the heart. The heart wall is a three layered structure with a thick layer of myocardium sandwiched between the inner endocardium and the outer epicardium (also known as the visceral pericardium). The inner endocardium lines the cardiac chambers, covers the cardiac valves, and joins with the endothelium that lines the blood vessels that connect to the heart. On the outer aspect of the myocardium is the epicardium which forms part of the pericardium, the sack that surrounds, protects, and lubricates the heart.^[1] Within the myocardium there are several sheets of cardiac muscle cells or cardiomyocytes. The sheets of muscle that wrap around the left ventricle closest to the endocardium are oriented perpendicularly to those closest to the epicardium. When these sheets contract in a coordinated manner they allow the ventricle to squeeze in several direction simultaneously – longitudinally (becoming shorter from apex to base), radially (becoming narrower from side to side), and with a twisting motion (similar to wringing out a damp cloth) to squeeze the maximum amount of blood out of the heart with each heartbeat.^[2]

Contracting heart muscle uses a lot of energy, and therefore requires a constant flow of blood to provide oxygen and nutrients. Blood is brought to the myocardium by the coronary arteries. These originate from the aortic root and lie on the outer or epicardial surface of the heart. Blood is then drained away by the coronary veins into the right atrium.^[1]

Histology

When looked at microscopically, cardiac muscle can be likened to the wall of a house. Most of the wall is taken up by bricks, which in cardiac muscle are individual cardiac muscle cells or cardiomyocytes. The mortar which surrounds the bricks is known as the extracellular matrix, produced by supporting cells known as fibroblasts. In the same way that the walls of a house contain electrical wires and plumbing, cardiac muscle also contains specialised cells for conducting electrical signals rapidly (the cardiac conduction system), and blood vessels to bring nutrients to the muscle cells and take away waste products (the coronary arteries, veins and capillary network).^[3]

Cardiac muscle cells

Cardiac muscle cells or cardiomyocytes are the contracting cells which allow the heart to pump. Each cardiomyocyte needs to contract in coordination with its neighbouring cells to efficiently pump blood from the heart, and if this coordination breaks down then – despite individual cells contracting – the heart may not pump at all, such as may occur during abnormal heart rhythms such as ventricular fibrillation.^[4]

Viewed through a microscope, cardiac muscle cells are roughly rectangular, measuring 100–150μm by 30–40μm.^[6] Individual cardiac muscle cells are joined together at their ends by intercalated disks to form long fibres. Each cell contains myofibrils, specialised protein fibres that slide past each other. These are organised into sarcomeres, the fundamental contractile units of muscle cells. The regular organisation of myofibrils into sarcomeres gives cardiac muscle cells a striped or striated appearance when looked at through a microscope, similar to skeletal muscle. These striations are caused by lighter I bands composed mainly of a protein called actin, and darker A bands composed mainly of myosin.^[3]

Cardiomyocytes contain T-tubules, pouches of membrane that run from the surface to the cell's interior which help to which improve the efficiency of contraction. The majority of these cells contain only one nucleus (although they may have as many as four), unlike skeletal muscle cells which typically contain many nuclei. Cardiac muscle cells contain many mitochondria which provide the energy needed for the cell in the form of adenosine triphosphate (ATP), making them highly resistant to fatigue.^[6]^[3]

T-tubules

T-tubules are microscopic tubes that run from the cell surface to deep within the cell. They are continuous with the cell membrane, are composed of the same phospholipid bilayer, and are open at the cell surface to the extracellular fluid that surrounds the cell. T-tubules in cardiac muscle are bigger and wider than those in skeletal muscle, but fewer in number.^[6] In the centre of the cell they join together, running into and along the cell as a transverse-axial network. Inside the cell they lie close to the cell's internal calcium store, the sarcoplasmic reticulum. Here, a single tubule pairs with part of the sarcoplasmic reticulum called a terminal cisterna in a combination known as a diad.^[5]

The functions of T-tubules include rapidly transmitting electrical impulses known as action potentials from the cell surface to the cell's core, and helping to regulate the concentration of calcium within the cell in a process known as excitation-contraction coupling.^[6]

Intercalated discs

The cardiac syncytium is a network of cardiomyocytes connected to each other by intercalated discs that enable the rapid transmission of electrical impulses through the network, enabling the syncytium to act in a coordinated contraction of the myocardium. There is an atrial syncytium and a ventricular syncytium that are connected by cardiac connection fibres.^[7] Electrical resistance through intercalated discs is very low, thus allowing free diffusion of ions. The ease of ion movement along cardiac muscle fibers axes is such that action potentials are able to travel from one cardiac muscle cell to the next, facing only slight resistance. Each syncytium obeys the all or none law.^[8]

Intercalated discs are complex adhering structures that connect the single cardiomyocytes to an electrochemical syncytium (in contrast to the skeletal muscle, which becomes a multicellular syncytium during mammalian embryonic development). The discs are responsible mainly for force transmission during muscle contraction. Intercalated discs consist of three different types of cell-cell junctions: the actin filament anchoring adherens junctions, the intermediate filament anchoring desmosomes, and gap junctions. They allow action potentials to spread between cardiac cells by permitting the passage of ions between cells, producing depolarization of the heart muscle. However, novel molecular biological and comprehensive studies unequivocally showed that intercalated discs consist for the most part of mixed-type adhering junctions named area composita (pl. areae compositae) representing an amalgamation of typical desmosomal and fascia adhaerens proteins (in contrast to various epithelia).^[9]^[10]^[11] The authors discuss the high importance of these findings for the understanding of inherited cardiomyopathies (such as arrhythmogenic right ventricular cardiomyopathy).

Under light microscopy, intercalated discs appear as thin, typically dark-staining lines dividing adjacent cardiac muscle cells. The intercalated discs run perpendicular to the direction of muscle fibers. Under electron microscopy, an intercalated disc's path appears more complex. At low magnification, this may appear as a convoluted electron dense structure overlying the location of the obscured Z-line. At high magnification, the intercalated disc's path appears even more convoluted, with both longitudinal and transverse areas appearing in longitudinal section.^[12]

Fibroblasts

Cardiac fibroblasts are vital supporting cells within cardiac muscle. They are unable to provide forceful contractions like cardiomyocytes, but instead are largely responsible for creating and maintaining the extracellular matrix which forms the mortar in which cardiomyocyte bricks are embedded.^[3] Fibroblasts play a crucial role in responding to injury, such as a myocardial infarction. Following injury, fibroblasts can become activated and turn into myofibroblasts – cells which exhibit behaviour somewhere between a fibroblast (generating extracellular matrix) and a smooth muscle cell (ability to contract). In this capacity, fibroblasts can repair an injury by creating collagen while gently contracting to pull the edges of the injured area together.^[13]

Fibroblasts are smaller but more numerous than cardiomyocytes, and several fibroblasts can be attached to a cardiomyocyte at once. When attached to a cardiomyocyte they can influence the electrical currents passing across the muscle cell's surface membrane, and in the context are referred to as being electrically coupled.^[14] Other potential roles for fibroblasts include electrical insulation of the cardiac conduction system, and the ability to transform into other cell types including cardiomyocytes and adipocytes.^[13]

Extracellular matrix

The matrix in immediate contact with the muscle cells is referred to as the basement membrane, mainly composed of type IV collagen and laminin. Cardiomyocytes are linked to the basement membrane via specialised glycoproteins called integrins.^[15]

Physiology

The physiology of cardiac muscle shares many similarities with that of skeletal muscle. The primary function of both muscle types is to contract, and in both cases a contraction begins with a characteristic flow of ions across the cell membrane known as an action potential. The action potential subsequently triggers muscle contraction by increasing the concentration of calcium within the cytosol.

However, the mechanism by which calcium concentrations within the cytosol rise differ between skeletal and cardiac muscle. In cardiac muscle, the action potential comprises an inward flow of both sodium and calcium ions. The flow of sodium ions is rapid but very short-lived, while the flow of calcium is sustained and gives the plateau phase characteristic of cardiac muscle action potentials. The comparatively small flow of calcium through the L-type calcium channels triggers a much larger release of calcium from the sarcoplasmic reticulum in a phenomenon known as calcium-induced calcium release. In contrast, in skeletal muscle, minimal calcium flows into the cell during action potential and instead the sarcoplasmic reticulum in these cells is directly coupled to the surface membrane. This difference can be illustrated by the observation that cardiac muscle fibres require calcium to be present in the solution surrounding the cell in order to contract, while skeletal muscle fibres will contract without extracellular calcium.

During contraction of a cardiac muscle cell, the long protein myofilaments oriented along the length of the slide over each other in what is known as the sliding filament hypothesis. There are two kinds of myofilaments, thick filaments composed of the protein myosin, and thin filaments composed of the proteins actin, troponin and tropomyosin. As the thick and thin filaments slide past each other the cell becomes shorter and fatter. In a mechanism known as crossbridge cycling, calcium ions bind to the protein troponin, which along with tropomyosin then uncover key binding sites on actin. Myosin, in the thick filament, can then bind to actin, pulling the thick filaments along the thin filaments. When the concentration of calcium within the cell falls, troponin and tropomyosin once again cover the binding sites on actin, causing the cell to relax.

Regeneration

Until recently, it was commonly believed that cardiac muscle cells could not be regenerated. However, a study reported in the April 3, 2009 issue of Science contradicts that belief.^[16] Olaf Bergmann and his colleagues at the Karolinska Institute in Stockholm tested samples of heart muscle from people born before 1955 who had very little cardiac muscle around their heart, many showing with disabilities from this abnormality. By using DNA samples from many hearts, the researchers estimated that a 4-year-old renews about 20% of heart muscle cells per year, and about 69 percent of the heart muscle cells of a 50-year-old were generated after he or she was born.

One way that cardiomyocyte regeneration occurs is through the division of pre-existing cardiomyocytes during the normal aging process.^[17] The division process of pre-existing cardiomyocytes has also been shown to increase in areas adjacent to sites of myocardial injury. In addition, certain growth factors promote the self-renewal of endogenous cardiomyocytes and cardiac stem cells. For example, insulin-like growth factor 1, hepatocyte growth factor, and high-mobility group protein B1 increase cardiac stem cell migration to the affected area, as well as the proliferation and survival of these cells.^[18] Some members of the fibroblast growth factor family also induce cell-cycle re-entry of small cardiomyocytes. Vascular endothelial growth factor also plays an important role in the recruitment of native cardiac cells to an infarct site in addition to its angiogenic effect.

Based on the natural role of stem cells in cardiomyocyte regeneration, researchers and clinicians are increasingly interested in using these cells to induce regeneration of damaged tissue. Various stem cell lineages have been shown to be able to differentiate into cardiomyocytes, including bone marrow stem cells. For example, in one study, researchers transplanted bone marrow cells, which included a population of stem cells, adjacent to an infarct site in a mouse model. Nine days after surgery, the researchers found a new band of regenerating myocardium.^[19] However, this regeneration was not observed when the injected population of cells was devoid of stem cells, which strongly suggests that it was the stem cell population that contributed to the myocardium regeneration. Other clinical trials have shown that autologous bone marrow cell transplants delivered via the infarct-related artery decreases the infarct area compared to patients not given the cell therapy.^[20]

Differences between atria and ventricles

Cardiac muscle forms both the atria and the ventricles of the heart. Although this muscle tissue is very similar between cardiac chambers, some differences exist. The myocardium found in the ventricles is thick to allow forceful contractions, while the myocardium in the atria is much thinner. The individual myocytes that make up the myocardium also differ between cardiac chambers. Ventricular cardiomyocytes are longer and wider, with a denser T-tubule network. Although the fundamental mechanisms of calcium handling are similar between ventricular and atrial cardiomyocytes, the calcium transient is smaller and decays more rapidly in atrial myocytes, with a corresponding increase in calcium buffering capacity.^[21] The complement of ion channels differs between chambers, leading to longer action potential durations and effective refractory periods in the ventricles. Certain ion currents such as I_K(UR) are highly specific to atrial cardiomyocytes, making them a potential target for treatments for atrial fibrillation.^[22]

Clinical significance

Diseases affecting cardiac muscle are of immense clinical significance, and are the leading cause of death in developed nations.^[23] The most common condition affecting cardiac muscle is ischaemic heart disease, in which the blood supply to the heart is reduced. In ischaemic heart disease, the coronary arteries become narrowed by atherosclerosis.^[24] If these narrowings gradually become severe enough to partially restrict blood flow, the syndrome of angina pectoris may occur.^[24] This typically causes chest pain during exertion that is relieved by rest. If a coronary artery suddenly becomes very narrowed or completed blocked, interrupting or severely reducing blood flow through the vessel, a myocardial infarction or heart attack occurs.^[25] If the blockage is not relieved promptly by medication, percutaneous coronary intervention, or surgery, then a region of heart muscle may become permanently scarred and damaged.^[26]

Heart muscle can also become damaged despite a normal blood supply. The heart muscle may become inflamed in a condition called myocarditis,^[27] most commonly caused by a viral infection^[28] but sometimes caused by the body's own immune system.^[29] Heart muscle can also be damaged by drugs such as alcohol, long standing high blood pressure or hypertension, or persistent abnormal heart racing.^[30] Specific diseases of heart muscle called cardiomyopathies can cause heart muscle to become abnormally thick (hypertrophic cardiomyopathy),^[31] abnormally large (dilated cardiomyopathy),^[32] or abnormally stiff (restrictive cardiomyopathy).^[33] Some of these conditions are caused by genetic mutations and can be inherited.^[34]

Many of these conditions, if severe enough, can damage the heart so much that the pumping function of the heart is reduced. If the heart is no longer able to pump enough blood to meet the body's needs, this is described as heart failure.^[30]

See also

References

1. ^¹{{Cite book|title=Last's anatomy : regional and applied.|last=S.|first=Sinnatamby, Chummy|date=2006|publisher=Elsevier/Churchill Livingstone|others=Last, R. J. (Raymond Jack).|isbn=978-0-443-10032-1|edition=11th|location=Edinburgh|oclc=61692701}}
2. ^{{Cite journal|last=Stöhr|first=Eric J.|last2=Shave|first2=Rob E.|last3=Baggish|first3=Aaron L.|last4=Weiner|first4=Rory B.|date=2016-09-01|title=Left ventricular twist mechanics in the context of normal physiology and cardiovascular disease: a review of studies using speckle tracking echocardiography|journal=American Journal of Physiology. Heart and Circulatory Physiology|volume=311|issue=3|pages=H633–644|doi=10.1152/ajpheart.00104.2016|issn=1522-1539|pmid=27402663|hdl=10369/9408}}
3. ^¹²³⁴{{Cite book|title=Human histology|last=(Pathologist)|first=Stevens, Alan|date=1997|publisher=Mosby|others=Lowe, J. S. (James Steven), Stevens, Alan (Pathologist).|isbn=978-0723424857|edition=2nd|location=London|oclc=35652355}}
4. ^{{Cite book|title=The ESC textbook of cardiovascular medicine|date=2009|publisher=Oxford University Press|others=Camm, A. John., Lüscher, Thomas F. (Thomas Felix), Serruys, P. W., European Society of Cardiology.|isbn=9780199566990|edition=2nd|location=Oxford|oclc=321015206}}
5. ^{{Cite journal|last=Hong|first=TingTing|last2=Shaw|first2=Robin M.|date=January 2017|title=Cardiac T-Tubule Microanatomy and Function|journal=Physiological Reviews|volume=97|issue=1|pages=227–252|doi=10.1152/physrev.00037.2015|issn=1522-1210|pmid=27881552|pmc=6151489}}
6. ^¹²³{{Cite book|title=Excitation-contraction coupling and cardiac contractile force|last=M.|first=Bers, D.|date=2001|publisher=Kluwer Academic Publishers|isbn=978-0792371588|edition=2nd|location=Dordrecht|oclc=47659382}}
7. ^{{cite book|author1=Jahangir Moini|author2=Professor of Allied Health Everest University Indialantic Florida Jahangir Moini|title=Anatomy and Physiology for Health Professionals|url=https://books.google.com/books?id=Z-QTQh1Fg8wC&pg=PA213|date=4 April 2011|publisher=Jones & Bartlett Publishers|isbn=978-1-4496-3414-8|pages=213–}}
8. ^{{cite book|author=Khurana|title=Textbook Of Medical Physiology|url=https://books.google.com/books?id=M6vviWpZ0LsC&pg=PA247|date=1 January 2005|publisher=Elsevier India|isbn=978-81-8147-850-4|pages=247}}
9. ^{{cite journal |vauthors=Franke WW, Borrmann CM, Grund C, Pieperhoff S |title=The area composita of adhering junctions connecting heart muscle cells of vertebrates. I. Molecular definition in intercalated disks of cardiomyocytes by immunoelectron microscopy of desmosomal proteins |journal=Eur. J. Cell Biol. |volume=85 |issue=2 |pages=69–82 |date=February 2006 |pmid=16406610 |doi=10.1016/j.ejcb.2005.11.003 |url=http://linkinghub.elsevier.com/retrieve/pii/S0171-9335(05)00196-2}}
10. ^{{cite journal |vauthors=Goossens S, Janssens B, Bonné S |title=A unique and specific interaction between alphaT-catenin and plakophilin-2 in the area composita, the mixed-type junctional structure of cardiac intercalated discs |journal=J. Cell Sci. |volume=120 |issue=Pt 12 |pages=2126–36 |date=June 2007 |pmid=17535849 |doi=10.1242/jcs.004713 |display-authors=etal}}
11. ^{{cite journal |vauthors=Pieperhoff S, Barth M, Rickelt S, Franke WW |veditors=Mahoney MG, Müller EJ, Koch PJ |title=Desmosomes and Desmosomal Cadherin Function in Skin and Heart Diseases-Advancements in Basic and Clinical Research |journal=Dermatol Res Pract |volume=2010 |year=2010 |pmid=20885972 |pmc=2946574 |doi=10.1155/2010/725647 |pages=1–3 }}
12. ^{{BUHistology|22501loa|inline=1}}
13. ^¹{{Cite journal|last=Ivey|first=Malina J.|last2=Tallquist|first2=Michelle D.|date=2016-10-25|title=Defining the Cardiac Fibroblast|journal=Circulation Journal: Official Journal of the Japanese Circulation Society|volume=80|issue=11|pages=2269–2276|doi=10.1253/circj.CJ-16-1003|issn=1347-4820|pmc=5588900|pmid=27746422}}
14. ^{{Cite journal|last=Rohr|first=Stephan|date=June 2009|title=Myofibroblasts in diseased hearts: new players in cardiac arrhythmias?|journal=Heart Rhythm|volume=6|issue=6|pages=848–856|doi=10.1016/j.hrthm.2009.02.038|issn=1556-3871|pmid=19467515}}
15. ^{{Cite journal|last=Horn|first=Margaux A.|last2=Trafford|first2=Andrew W.|date=April 2016|title=Aging and the cardiac collagen matrix: Novel mediators of fibrotic remodelling|journal=Journal of Molecular and Cellular Cardiology|volume=93|pages=175–185|doi=10.1016/j.yjmcc.2015.11.005|issn=1095-8584|pmc=4945757|pmid=26578393}}
16. ^{{cite journal |vauthors=Bergmann O, Bhardwaj RD, Bernard S |title=Evidence for cardiomyocyte renewal in humans |journal=Science |volume=324 |issue=5923 |pages=98–102 |date=April 2009 |pmid=19342590 |pmc=2991140 |doi=10.1126/science.1164680 |display-authors=etal}}
17. ^{{cite journal |vauthors=Senyo SE, Steinhauser ML, Pizzimenti CL, Yang VK, Cai L, Wang M, Wu TD, Guerguin-Kern JL, Lechene CP, Lee RT |title=Mammalian heart renewal by pre-existing cardiomyocytes |journal=Nature |volume=493 |issue=7432 |pages=433–6 |date=January 2013 |pmid=23222518 |pmc=3548046 |doi=10.1038/nature11682 }}
18. ^{{cite journal |vauthors=Germani A, Di Rocco G, Limana F, Martelli F, Capogrossi MC |title=Molecular mechanisms of cardiomyocyte regenerate and therapeutic outlook |journal=Trends Mol Med |volume=13 |issue=3 |pages=125–33 |date=March 2007 |pmid=17257896 |doi=10.1016/j.molmed.2007.01.002 |url=http://www.cell.com/trends/molecular-medicine/abstract/S1471-4914(07)00003-2}}
19. ^{{cite journal |vauthors=Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel K, McKay R, Nadal-Ginard B, Bodine DM, Anversa P |title=Bone marrow cells regenerate infarcted myocardium |journal=Nature |volume=410 |issue=6829 |pages=701–5 |date=April 2001 |pmid=11287958 |doi=10.1038/35070587 }}
20. ^{{cite journal |vauthors=Orlic D, Hill JM, Arai AE |title=Stem cells for myocardial regeneration |journal=Circ Res |volume=91 |issue=12 |pages=1092–102 |date=December 2002 |pmid=12480809 |doi=10.1161/01.RES.0000046045.00846.B0 |url=http://circres.ahajournals.org/content/91/12/1092.abstract}}
21. ^{{Cite journal|last=Walden|first=A. P.|last2=Dibb|first2=K. M.|last3=Trafford|first3=A. W.|date=April 2009|title=Differences in intracellular calcium homeostasis between atrial and ventricular myocytes|journal=Journal of Molecular and Cellular Cardiology|volume=46|issue=4|pages=463–473|doi=10.1016/j.yjmcc.2008.11.003|issn=1095-8584|pmid=19059414}}
22. ^{{Cite journal|last=Ravens|first=Ursula|last2=Wettwer|first2=Erich|date=2011-03-01|title=Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications|journal=Cardiovascular Research|volume=89|issue=4|pages=776–785|doi=10.1093/cvr/cvq398|issn=1755-3245|pmid=21159668}}
23. ^{{Cite journal|last=Lozano|first=Rafael|last2=Naghavi|first2=Mohsen|last3=Foreman|first3=Kyle|last4=Lim|first4=Stephen|last5=Shibuya|first5=Kenji|last6=Aboyans|first6=Victor|last7=Abraham|first7=Jerry|last8=Adair|first8=Timothy|last9=Aggarwal|first9=Rakesh|date=2012-12-15|title=Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010|journal=Lancet|volume=380|issue=9859|pages=2095–2128|doi=10.1016/S0140-6736(12)61728-0|issn=1474-547X|pmid=23245604}}
24. ^¹{{Cite journal|last=Kolh|first=Philippe|last2=Windecker|first2=Stephan|last3=Alfonso|first3=Fernando|last4=Collet|first4=Jean-Philippe|last5=Cremer|first5=Jochen|last6=Falk|first6=Volkmar|last7=Filippatos|first7=Gerasimos|last8=Hamm|first8=Christian|last9=Head|first9=Stuart J.|date=October 2014|title=2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)|journal=European Journal of Cardio-Thoracic Surgery|volume=46|issue=4|pages=517–592|doi=10.1093/ejcts/ezu366|issn=1873-734X|pmid=25173601}}
25. ^{{Cite journal|last=Smith|first=Jennifer N.|last2=Negrelli|first2=Jenna M.|last3=Manek|first3=Megha B.|last4=Hawes|first4=Emily M.|last5=Viera|first5=Anthony J.|date=March 2015|title=Diagnosis and management of acute coronary syndrome: an evidence-based update|journal=Journal of the American Board of Family Medicine: JABFM|volume=28|issue=2|pages=283–293|doi=10.3122/jabfm.2015.02.140189|issn=1558-7118|pmid=25748771}}
26. ^{{Cite journal|last=Roffi|first=Marco|last2=Patrono|first2=Carlo|last3=Collet|first3=Jean-Philippe|last4=Mueller|first4=Christian|last5=Valgimigli|first5=Marco|last6=Andreotti|first6=Felicita|last7=Bax|first7=Jeroen J.|last8=Borger|first8=Michael A.|last9=Brotons|first9=Carlos|date=2016-01-14|title=2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)|journal=European Heart Journal|volume=37|issue=3|pages=267–315|doi=10.1093/eurheartj/ehv320|issn=1522-9645|pmid=26320110}}
27. ^{{Cite journal|last=Cooper|first=Leslie T.|date=2009-04-09|title=Myocarditis|journal=The New England Journal of Medicine|volume=360|issue=15|pages=1526–1538|doi=10.1056/NEJMra0800028|issn=1533-4406|pmc=5814110|pmid=19357408}}
28. ^{{Cite journal|last=Rose|first=Noel R.|date=July 2016|title=Viral myocarditis|journal=Current Opinion in Rheumatology|volume=28|issue=4|pages=383–389|doi=10.1097/BOR.0000000000000303|issn=1531-6963|pmc=4948180|pmid=27166925}}
29. ^{{Cite book|last=Bracamonte-Baran|first=William|last2=Čiháková|first2=Daniela|date=2017|title=Cardiac Autoimmunity: Myocarditis|journal=Advances in Experimental Medicine and Biology|volume=1003|pages=187–221|doi=10.1007/978-3-319-57613-8_10|issn=0065-2598|pmc=5706653|pmid=28667560|isbn=978-3-319-57611-4}}
30. ^¹{{Cite journal|last=Ponikowski|first=Piotr|last2=Voors|first2=Adriaan A.|last3=Anker|first3=Stefan D.|last4=Bueno|first4=Héctor|last5=Cleland|first5=John G. F.|last6=Coats|first6=Andrew J. S.|last7=Falk|first7=Volkmar|last8=González-Juanatey|first8=José Ramón|last9=Harjola|first9=Veli-Pekka|date=August 2016|title=2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC|journal=European Journal of Heart Failure|volume=18|issue=8|pages=891–975|doi=10.1002/ejhf.592|issn=1879-0844|pmid=27207191}}
31. ^{{Cite journal|last=Liew|first=Alphonsus C.|last2=Vassiliou|first2=Vassilios S.|last3=Cooper|first3=Robert|last4=Raphael|first4=Claire E.|date=2017-12-12|title=Hypertrophic Cardiomyopathy-Past, Present and Future|journal=Journal of Clinical Medicine|volume=6|issue=12|pages=118|doi=10.3390/jcm6120118|issn=2077-0383|pmc=5742807|pmid=29231893}}
32. ^{{Cite journal|last=Japp|first=Alan G.|last2=Gulati|first2=Ankur|last3=Cook|first3=Stuart A.|last4=Cowie|first4=Martin R.|last5=Prasad|first5=Sanjay K.|date=2016-06-28|title=The Diagnosis and Evaluation of Dilated Cardiomyopathy|journal=Journal of the American College of Cardiology|volume=67|issue=25|pages=2996–3010|doi=10.1016/j.jacc.2016.03.590|issn=1558-3597|pmid=27339497}}
33. ^{{Cite journal|last=Garcia|first=Mario J.|date=2016-05-03|title=Constrictive Pericarditis Versus Restrictive Cardiomyopathy?|journal=Journal of the American College of Cardiology|volume=67|issue=17|pages=2061–2076|doi=10.1016/j.jacc.2016.01.076|issn=1558-3597|pmid=27126534}}
34. ^{{Cite journal|last=Towbin|first=Jeffrey A.|date=2014|title=Inherited cardiomyopathies|journal=Circulation Journal: Official Journal of the Japanese Circulation Society|volume=78|issue=10|pages=2347–2356|issn=1347-4820|pmc=4467885|pmid=25186923|doi=10.1253/circj.CJ-14-0893}}